<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97509">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01984957</url>
  </required_header>
  <id_info>
    <org_study_id>P110401</org_study_id>
    <nct_id>NCT01984957</nct_id>
  </id_info>
  <brief_title>Differential Study of Muscle Transcriptome</brief_title>
  <acronym>TRANE</acronym>
  <official_title>Differential Study of Muscle Transcriptome in Patients With Neuromuscular Disease and Control Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DGOS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To isolate biomarkers of ALS in muscle
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At present, there is no validated biological diagnostic marker for amyotrophic lateral
      sclerosis (ALS). The main objective of the study is to isolate a set of genes that are
      specifically dysregulated in muscle from ALS patients.

      Gene profiling in muscle will be compared between ALS patients and patients with other
      motor neuron diseases (SMA and SBMA)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Gene expression levels</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Gene expression levels in muscle as determined By microarrays (transcriptome analysis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle denervation</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Severity of muscle denervation as determined by histological analysis of muscle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional evaluation</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>ALSFRS-R, Manual Muscle Testing and Slow Vital Capacity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>ALS</condition>
  <condition>SMA</condition>
  <condition>SBMA</condition>
  <arm_group>
    <arm_group_label>disease (ALS, SMA or SBMA)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>muscle biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Muscle biopsy</intervention_name>
    <description>open muscular biopsy of the deltoid under local anaesthesia</description>
    <arm_group_label>disease (ALS, SMA or SBMA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :

        - Patient with ALS,  SMA, or SBMA

        Exclusion criteria :

          -  Indication against biopsy (allergy to anesthetics local haemostasis disorders)

          -  Treatments that can affect muscle metabolism
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Francois Pradat, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PRADAT Pierre-Francois, MD, PhD</last_name>
    <phone>33 1 4216 24 71</phone>
    <email>Pierre-françois.pradat@psl.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre d'évaluation Thérapeutique, Dr LACOMBLEZ</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Francois Pradat, MD, PhD</last_name>
      <phone>33 1 4216 24 71</phone>
    </contact>
    <investigator>
      <last_name>Pierre-Francois Pradat, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>June 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ALS</keyword>
  <keyword>Motor neuron diseases</keyword>
  <keyword>Transcriptome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
